Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome

3 Sept 2019

Abstract excerpt

PROBLEM: As antiphospholipid antibody-positive women with adverse pregnancy outcomes have higher plasma complement activation product levels, and the placentas of women with antiphospholipid syndrome (APS) exhibit C4d complement component deposition, complement activation involvement has been hypothesized in APS pregnancy complications. METHOD OF STUDY: Plasma levels of C5a and C5b-9 complement components of 43...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Liver Diseases and Immunity
Share to Renal Diseases and Glomerulopathies
Share to Systemic Lupus Erythematosus Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31479579
DOI: 10.1111/aji.13185

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndromePMID 31479579Read ↗

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic ImplicationsSemantic proximity Read ↗

Complement in antiphospholipid syndrome, time to target?Semantic proximity Read ↗

The role of complement in normal pregnancy and preeclampsiaSemantic proximity Read ↗

The complement system and adverse pregnancy outcomes.Semantic proximity Read ↗

Understanding antiphospholipid syndrome clinical phenotypes with the guidance of antiphospholipid antibody-related pathogenic mechanisms.Semantic proximity Read ↗

Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic MechanismsSemantic proximity Read ↗

Molecular Advances in Preeclampsia and HELLP SyndromeSemantic proximity Read ↗

Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome.Semantic proximity Read ↗

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndromeSemantic proximity Read ↗

Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications.Semantic proximity Read ↗

Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)Semantic proximity Read ↗

Complement 5a-mediated trophoblasts dysfunction is involved in the development of pre-eclampsia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.